Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.35 - $0.74 $64,835 - $137,080
-185,244 Reduced 91.51%
17,184 $6,000
Q1 2023

May 18, 2023

BUY
$0.72 - $1.21 $89,285 - $150,049
124,008 Added 158.13%
202,428 $155,000
Q1 2023

May 11, 2023

SELL
$0.72 - $1.21 $87,652 - $147,305
-121,740 Reduced 60.82%
78,420 $60,000
Q4 2022

Feb 13, 2023

SELL
$0.82 - $1.36 $1,007 - $1,671
-1,229 Reduced 0.61%
200,160 $183,000
Q3 2022

Nov 14, 2022

SELL
$0.91 - $2.27 $9,202 - $22,956
-10,113 Reduced 4.78%
201,389 $187,000
Q2 2022

Aug 11, 2022

SELL
$1.5 - $2.57 $78,523 - $134,536
-52,349 Reduced 19.84%
211,502 $450,000
Q1 2022

May 11, 2022

SELL
$1.99 - $3.0 $41,992 - $63,306
-21,102 Reduced 7.41%
263,851 $612,000
Q4 2021

Feb 10, 2022

BUY
$2.14 - $3.31 $316,287 - $489,211
147,798 Added 107.76%
284,953 $880,000
Q3 2021

Nov 12, 2021

BUY
$2.86 - $4.21 $392,263 - $577,422
137,155 New
137,155 $406,000

Others Institutions Holding XXII

About 22nd Century Group, Inc.


  • Ticker XXII
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Tobacco
  • Shares Outstandng 214,784,992
  • Market Cap $155M
  • Description
  • 22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King n...
More about XXII
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.